Mitogen-activated protein kinases

Critical Care Medicine

Volumn 30, Issue 1 SUPPL. B, 2002, Pages

  Arbabi, Saman ^a   Maier, Ronald V ^a  

^a Urology Institute Case Medical Center University Hospitals   (United States)

Author keywords

Adult respiratory distress syndrome; c Jun N terminal kinase; Critical care; Cytokine; Extracellular signal regulated kinase; Mitogen activated protein kinase; Multiple organ dysfunction syndrome; p38; Signal transduction; Systemic inflammatory response syndrome

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN INHIBITOR; SB 03580; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ADULT RESPIRATORY DISTRESS SYNDROME; CONFERENCE PAPER; ENZYME ACTIVATION; ENZYME INHIBITION; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0036162009     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200201001-00010     Document Type: Conference Paper

References (118)

1. Lipid mediators in the pathophysiology of critical illness
2. Normal responses to injury prevent systemic inflammation and can be immunosuppressive
3. The MAPK signaling cascade
4. Mitogen-activated protein kinase pathways
5. How MAP kinases are regulated
6. Signal transduction by the JNK group of MAP kinases
7. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta
8. Signal transduction by the c-Jun N-terminal kinase (JNK) - From inflammation to development
9. Sequential protein kinase reactions controlling cell growth and differentiation
10. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells
11. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
12. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine
13. Osmotic regulation of cytokine synthesis in vitro
14. Murine p38-delta mitogen-activated protein kinase, a developmentally regulated protein kinase that is activated by stress and proinflammatory cytokines
15. Novel homologues of CSBP/p38 MAP kinase: Activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles
16. Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils
17. Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta)
18. The primary structure of p38 gamma: A new member of p38 group of MAP kinases
19. MAP kinase pathways activated by stress: The p38 MAPK pathway
20. Mechanism of action of bicyclic imidazoles defines a translational regulatory pathway for tumor necrosis factor alpha
21. The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs)
22. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase
23. SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis
24. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6): Comparison of the specificities of SAPK3 and SAPK2 (RK/p38)
25. Cloning and characterization of MEK6, a novel member of the mitogen-activated protein kinase kinase cascade
26. Characterization of the structure and function of a novel MAP kinase kinase (MKK6)
27. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression
28. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6
29. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation
30. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins
31. Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase
32. Identification of two distinct regions of p38 MAPK required for substrate binding and phosphorylation
33. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1
34. A comparison of the substrate specificity of MAPKAP kinase-2 and MAPKAP kinase-3 and their activation by cytokines and cellular stress
35. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2
36. Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins
37. Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27
38. Exaggerated human monocyte IL-10 concomitant to minimal TNF-alpha induction by heat-shock protein 27 (Hsp27) suggests Hsp27 is primarily an antiinflammatory stimulus
39. ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation
40. Transcriptional activation by recruitment
41. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets: Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2
42. Identification by mass spectrometry of threonine 97 in bovine myelin basic protein as a specific phosphorylation site for mitogen-activated protein kinase
43. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2
44. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates
45. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation
46. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase
47. Convergence of MAP kinase pathways on the ternary complex factor Sap-1a
48. Induction of Ets-1 in endothelial cells during reendothelialization after denuding injury
49. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor
50. Activation of transcription factor NF-kappaB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways
51. The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression: The role of TATA-binding protein (TBP)
52. MKK6 activates myocardial cell NF-kappaB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner
53. Priming interleukin 8 production: Role of platelet-activating factor and p38
54. Activation of a p38 mitogen-activated protein kinase in human neutrophils by lipopolysaccharide
55. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP
56. Inhibitors of the p38 mitogen-activated kinase modulate IL-4 induction of low affinity IgE receptor (CD23) in human monocytes
57. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: Regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels
58. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney
59. SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes
60. Adherence regulates macrophage signal transduction and primes tumor necrosis factor production
61. Alcohol (ethanol) inhibits IL-8 and TNF: Role of the p38 pathway
62. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes
63. Inhibition of p38 kinase reveals a TNF-alpha-mediated, caspase-dependent, apoptotic death pathway in a human myelomonocyte cell line
64. p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or FMLP stimulation
65. Maximal human neutrophil priming for superoxide production and elastase release requires p38 mitogen-activated protein kinase activation
66. Hypertonic saline solution induces prostacyclin production by increasing cyclooxygenase-2 expression
67. Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways
68. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain
69. The stress-activated protein kinase subfamily of c-Jun kinases
70. Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation
71. Signaling from the small GTP-binding proteins Rac1 and Cdc42 to the c-Jun N-terminal kinase/stress-activated protein kinase pathway: A role for mixed lineage kinase 3/protein-tyrosine kinase 1, a novel member of the mixed lineage kinase family
72. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1
73. c-Jun N-terminal kinase (JNK) repression during the inflammatory response? Just say NO
74. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies
75. Mast cell tumor necrosis factor alpha production is regulated by MEK kinases
76. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: Glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK
77. Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes
78. An inhibitor of p38 and JNK MAP kinases prevents activation of caspase and apoptosis of cultured cerebellar granule neurons
79. Differential role of the JNK and p38 MAPK pathway in c-Mye- and s-Myc-mediated apoptosis
80. p38 mitogen-activated protein kinase regulates a novel, caspase-independent pathway for the mitochondrial cytochrome c release in ultraviolet B radiation-induced apoptosis
81. Signalling for survival and death in neurones: The role of stress-activated kinases, JNK and p38
82. Meaningful relationships: The regulation of the Ras/Raf/MEK/ERK pathway by protein interactions
83. A synthetic inhibitor of the mitogen-activated protein kinase cascade
84. Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin
85. Interactions of calcium/calmodulin-dependent protein kinases (CaMK) and extracellular-regulated kinase (ERK) in monocyte adherence and TNFalpha production
86. Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src
87. Integrin-mediated signals regulated by members of the rho family of GTPases
88. Extracellular signals and reversible protein phosphorylation: What to Mek of it all
89. Phorbol ester stimulates a protein-tyrosine/threonine kinase that phosphorylates and activates the Erk-1 gene product
90. The ins and outs of Raf kinases
91. Diversity in function and regulation of MAP kinase pathways
92. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
93. The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338
94. Activation of ternary complex factor Elk-1 by MAP kinases
95. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
96. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
97. Ras and Rho GTPases: A family reunion
98. Stress-induced inhibition of ERK1 and ERK2 by direct interaction with p38 MAP kinase
99. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms
100. The path to specificity
101. Routing MAP kinase cascades
102. Signaling through scaffold, anchoring, and adaptor proteins
103. Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest
104. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers
105. Association of mitogen-activated protein kinase with the microtubule cytoskeleton
106. The regulation of AP-1 activity by mitogen-activated protein kinases
107. Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB
108. Cellular signaling in critical care - Putting the pieces together
109. Mitogen-activated protein kinase (MAPK) in the ICU: Potential prognostic factors
110. Impaired mitogen-activated protein kinase activation and altered cytokine secretion in endotoxin-tolerant human monocytes
111. Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia
112. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion
113. Inhibition of p38 MAPK alpha/beta reduces ischemic injury and does not block protective effects of preconditioning
114. Inhibition of p38 mitogen activate kinase attenuates the severity of pancreatitis-induced adult respiratory distress syndrome
115. p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo
116. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue
117. Effect of SB 203580 on the activity of c-Raf in vitro and in vivo
118. Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580